Sanctuary Advisors LLC Buys New Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sanctuary Advisors LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 5,660 shares of the company’s stock, valued at approximately $417,000.

A number of other large investors have also added to or reduced their stakes in ACHC. Blue Trust Inc. increased its stake in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. Mather Group LLC. bought a new stake in Acadia Healthcare in the 1st quarter worth approximately $48,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $59,000. nVerses Capital LLC bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $95,000. Finally, Innealta Capital LLC bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $164,000.

Acadia Healthcare Price Performance

ACHC opened at $57.39 on Thursday. The business has a fifty day moving average of $71.37 and a 200 day moving average of $69.79. Acadia Healthcare Company, Inc. has a 52-week low of $53.22 and a 52-week high of $87.77. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a market cap of $5.32 billion, a P/E ratio of -409.93, a PEG ratio of 1.57 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same period in the prior year, the business earned $0.92 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. KeyCorp assumed coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Barclays cut their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.